ATE223228T1 - Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung. - Google Patents
Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung.Info
- Publication number
- ATE223228T1 ATE223228T1 AT98903122T AT98903122T ATE223228T1 AT E223228 T1 ATE223228 T1 AT E223228T1 AT 98903122 T AT98903122 T AT 98903122T AT 98903122 T AT98903122 T AT 98903122T AT E223228 T1 ATE223228 T1 AT E223228T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- medication
- latency
- production
- wound healing
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000029663 wound healing Effects 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000003102 growth factor Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003176 fibrotic effect Effects 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 231100000241 scar Toxicity 0.000 abstract 1
- 230000009772 tissue formation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9702943.3A GB9702943D0 (en) | 1997-02-13 | 1997-02-13 | Wound healing |
| PCT/GB1998/000316 WO1998035695A1 (en) | 1997-02-13 | 1998-02-13 | Wound healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE223228T1 true ATE223228T1 (de) | 2002-09-15 |
Family
ID=10807557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98903122T ATE223228T1 (de) | 1997-02-13 | 1998-02-13 | Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6319907B1 (https=) |
| EP (1) | EP1009425B1 (https=) |
| JP (1) | JP4307561B2 (https=) |
| AT (1) | ATE223228T1 (https=) |
| AU (1) | AU728851B2 (https=) |
| CA (1) | CA2280873C (https=) |
| DE (1) | DE69807710T2 (https=) |
| DK (1) | DK1009425T3 (https=) |
| ES (1) | ES2181165T3 (https=) |
| GB (1) | GB9702943D0 (https=) |
| PT (1) | PT1009425E (https=) |
| WO (1) | WO1998035695A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6756060B1 (en) * | 1996-09-19 | 2004-06-29 | Usbiomaterials Corp. | Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| EP1296704A4 (en) * | 2000-06-14 | 2005-04-27 | Chanda Bhuwalka Zaveri | PEPTIDES WITH PHYSIOLOGICAL ACTIVITY |
| US20060258562A1 (en) * | 2000-07-31 | 2006-11-16 | Healor Ltd. | Methods and pharmaceutical compositions for healing wounds |
| US20100129332A1 (en) * | 2000-07-31 | 2010-05-27 | Tamar Tennenbaum | Methods and pharmaceutical compositions for healing wounds |
| US20040037828A1 (en) * | 2002-07-09 | 2004-02-26 | Bar-Ilan University | Methods and pharmaceutical compositions for healing wounds |
| US20030148924A1 (en) * | 2002-07-09 | 2003-08-07 | Tamar Tennenbaum | Methods and pharmaceutical compositions of healing wounds |
| CA2416788A1 (en) * | 2000-07-31 | 2002-02-07 | Tamar Tennenbaum | Methods and pharmaceutical compositions comprising protein kinase c isoforms for healing wounds |
| WO2005016254A2 (en) * | 2003-07-16 | 2005-02-24 | The Ohio State University Research Foundation | Methods and reagents for treating inflammation and fibrosis |
| WO2005013885A2 (en) | 2003-08-07 | 2005-02-17 | Healor Ltd. | Pharmaceutical compositions and methods for accelerating wound healing |
| EP2452686A3 (en) * | 2005-08-29 | 2012-09-05 | HealOr Ltd. | Methods and compositions for prevention and treatment of diabetic and aged skin |
| EP2091557A2 (en) | 2006-11-15 | 2009-08-26 | Coda Therapeutics, INC. | Improved methods and compositions for wound healing |
| CN102755649A (zh) * | 2007-07-30 | 2012-10-31 | 希尔洛有限公司 | 药物组合物及相关方法 |
| CA2701420C (en) * | 2007-10-29 | 2016-02-09 | Helix Biomedix Inc. | Protective skin care tetrapeptides |
| AU2008343758A1 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| CA2710375A1 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Treatment of orthopedic conditions |
| JP2011507599A (ja) | 2007-12-21 | 2011-03-10 | コーダ セラピューティクス， インコーポレイテッド | 改良医療デバイス |
| US20100172217A1 (en) * | 2009-01-08 | 2010-07-08 | Von Bezold Ernst | System of Methods and Apparati for Handling and Modifying Information Energy and Matter by Formative Resonance |
| CA2751156A1 (en) * | 2009-02-24 | 2010-09-02 | Healor Ltd. | Visfatin therapeutic agents for the treatment of acne and other conditions |
| EP2523677A2 (en) | 2010-01-11 | 2012-11-21 | Healor Ltd. | Method for treatment of inflammatory disease and disorder |
| US9387183B2 (en) | 2011-12-28 | 2016-07-12 | Kuwait University | Method of treating diabetes-related impaired wound healing |
| US10465188B2 (en) | 2014-08-22 | 2019-11-05 | Auckland Uniservices Limited | Channel modulators |
| US10232009B1 (en) * | 2017-09-29 | 2019-03-19 | Pro Sunfun Biotech Research And Development Co., Ltd. | Peptide for promoting wound healing, its composition and method of using the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0502036B1 (en) | 1989-11-22 | 1995-12-20 | Genentech, Inc. | Latency associated peptide and uses therefor |
| GB9106678D0 (en) | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
| WO1994009812A1 (en) | 1992-10-26 | 1994-05-11 | Kirin Brewery Company, Limited | METHOD FOR PRODUCING LARGE LATENT TRANSFORMING GROWTH FACTOR-β COMPLEXES AND LARGE LATENCY ASSOCIATED PEPTIDE |
| US6074840A (en) * | 1994-02-18 | 2000-06-13 | The Regents Of The University Of Michigan | Recombinant production of latent TGF-beta binding protein-3 (LTBP-3) |
| WO1995026203A1 (en) * | 1994-03-29 | 1995-10-05 | The Victoria University Of Manchester | Wound healing |
-
1997
- 1997-02-13 GB GBGB9702943.3A patent/GB9702943D0/en active Pending
-
1998
- 1998-02-13 DK DK98903122T patent/DK1009425T3/da active
- 1998-02-13 ES ES98903122T patent/ES2181165T3/es not_active Expired - Lifetime
- 1998-02-13 EP EP98903122A patent/EP1009425B1/en not_active Expired - Lifetime
- 1998-02-13 AU AU59953/98A patent/AU728851B2/en not_active Ceased
- 1998-02-13 DE DE69807710T patent/DE69807710T2/de not_active Expired - Lifetime
- 1998-02-13 WO PCT/GB1998/000316 patent/WO1998035695A1/en not_active Ceased
- 1998-02-13 AT AT98903122T patent/ATE223228T1/de active
- 1998-02-13 CA CA2280873A patent/CA2280873C/en not_active Expired - Fee Related
- 1998-02-13 US US09/367,262 patent/US6319907B1/en not_active Expired - Fee Related
- 1998-02-13 JP JP53544198A patent/JP4307561B2/ja not_active Expired - Fee Related
- 1998-02-13 PT PT98903122T patent/PT1009425E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5995398A (en) | 1998-09-08 |
| WO1998035695A1 (en) | 1998-08-20 |
| CA2280873A1 (en) | 1998-08-20 |
| US6319907B1 (en) | 2001-11-20 |
| HK1025504A1 (en) | 2000-11-17 |
| PT1009425E (pt) | 2002-11-29 |
| JP2001511797A (ja) | 2001-08-14 |
| GB9702943D0 (en) | 1997-04-02 |
| DE69807710D1 (de) | 2002-10-10 |
| EP1009425A1 (en) | 2000-06-21 |
| DE69807710T2 (de) | 2003-06-05 |
| EP1009425B1 (en) | 2002-09-04 |
| CA2280873C (en) | 2010-04-06 |
| DK1009425T3 (da) | 2002-10-14 |
| ES2181165T3 (es) | 2003-02-16 |
| AU728851B2 (en) | 2001-01-18 |
| JP4307561B2 (ja) | 2009-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE223228T1 (de) | Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung. | |
| DE69229729D1 (de) | Wundheilung | |
| Su et al. | The problem scar | |
| Yarborough Jr | Ablation of facial scars by programmed dermabrasion | |
| PT646012E (pt) | Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3 | |
| WO2001007067A3 (en) | Solutions and methods for inhibition of pain, inflammation and cartilage degradation | |
| CA2183871A1 (en) | Platelet growth accelerator | |
| US4485088A (en) | Method of treatment of fibrotic lesions by topical administration of lathyrogenic drugs | |
| EP1289537B1 (en) | Method of treating chronic ulcers | |
| DE50014532D1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| DE59600683D1 (de) | Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten | |
| DE69829202D1 (de) | Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen | |
| ATE201598T1 (de) | Verwendung von moxonidin zur behandlung neuropathischer schmerzen | |
| US6174541B1 (en) | Skin aging and wound treatment using cell migration agents | |
| SE9101840L (sv) | Ny medicinsk anvaendning | |
| ATE297739T1 (de) | Endothelin-antagonisten zur behandlung von herzversagen | |
| Ksander et al. | Inhibition of connective tissue formation in dermal wounds covered with synthetic, moisture vapor-permeable dressings and its reversal by transforming growth factor-β | |
| DE69917756D1 (de) | Methoden zur behandlung von neurombedingten schmerzen | |
| ATE224727T1 (de) | Faktor xiii zur behandlung von hautwunden | |
| Pandit et al. | The effect on wound healing by a modified fibrin scaffold delivering acidic fibroblast growth factor (FGF-1) | |
| CA1077837A (en) | Hydrolytic enzyme material | |
| DE69732851D1 (de) | Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren | |
| CN115414524A (zh) | 重组人ⅲ型胶原蛋白水凝胶敷料在防治烧伤瘢痕中的应用 | |
| DE69509657D1 (de) | Verwendung von benzothiophenen zur herstellung eines medikaments zur verminderung der narbenbildung bei der wundheilung | |
| CA2165271A1 (en) | Reduction of adipose tissue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |